Michael May CCRM retweeted
Blogger @CalStrode sits down with @PZandstra @SBME_UBC "a new kind of influencer." Their wide-ranging discussion covers the professional (#CGT, cell fate, #AI, future predictions, and more) and the personal. signalsblog.ca/a-new-kind-of…
Michael May CCRM retweeted
At the Advanced Therapies Awards with @MichaelMay5 and his wife. Congratulations @Phacilitate on a lovely evening #ATW2023
Michael May CCRM retweeted
Holiday reading! Here @joelostblom and @emergentcell defined the minimal criteria for symmetry breaking -- a key developmental step in body-plan formation. Congratulations! Symmetry-breaking in adherent pluripotent stem cell-derived developmental patterns biorxiv.org/content/10.1101/…
Michael May CCRM retweeted
Again this year, we were pleased to support the trainees taking part in OHRI's Research Day @OttawaHospital. You can find this year's winners here: ohri.ca/newsroom/story/view/…
Michael May CCRM retweeted
Is #biomanufacturing on everyone's minds right now? It seems so. @msstaceyerin covers the topic once again, this time sharing insights from experts at a @JNJInnovation @JLABS @CCRM_ca event and giving a shoutout to @3M and @Phacilitate. signalsblog.ca/right-turn-ex…
Michael May CCRM retweeted
Congratulations on this milestone CTO! Keep up the good work.
Our Decade of Impact report highlights the Ontario #clinicaltrials community’s collective success and CTO’s initiatives. Read the report here: bit.ly/3E7fYkZ #CTODecadeofImpact
Michael May CCRM retweeted
.@creativedlab and @CCRM_ca launched its global #AdvancedTherapies stream with an event last month. Guest blogger @Leili_Rohani was there and shares her takeaways signalsblog.ca/takeaway-from…
Michael May CCRM retweeted
Many thanks to the environment created and sustained by Carl June and colleagues @PennMedicine @ChildrensPhila & #CelliconValley
thrilled that Bruce Levine to receive PMWC 2023 Pioneer Award. linkedin.com/posts/pmwcintl_…
Michael May CCRM retweeted
Later today, Dr Ryan Hicks, Dr Monique Watts and A/Prof Mikael Martino will discuss #RegenerativeMedicine approaches to cardiac-related conditions from their experience as industry, clinician-researcher, and medical researcher. Register before 2 pm for the Zoom link.
#Cardiology
ICYMI - This first webinar of the #InspirationSeries will look into #RegenMed approaches to #cardiac-related conditions from the perspectives of #MedicalResearcher, #ClinicianResearch and #Industry.
Time: 3-4 pm, AEDT
Register via docs.google.com/forms/d/1V4K…
#Cardiology
Michael May CCRM retweeted
Up now @3M Canada's #biomanufacturing event is Mitchel Sivilotti, CEO of #OmniaBio, @CCRM_ca's subsidiary. He's providing an overview of the company's focused #CGT manufacturing from early to late-stage manufacturing for domestic and intl therapy developers cc @MIP_Hamilton
Michael May CCRM retweeted
John Bell @BioCanRx on what academics need from #biomanufacturing: affordable, high quality manufacturing and access for early-phase testing, HQPs trained in #GMP (@CATTI_Training!) and facilities that are nimble @3M @CCRM_ca @OBIOscience @LifeSciencesON
Michael May CCRM retweeted
My second time listening to the frank and informative @MarkLievonen on pandemic preparedness from the POV of the #COVID19 taskforce @3M @CCRM_ca @LifeSciencesON @OBIOscience
Michael May CCRM retweeted
How #OmniaBio will support clients and tackle the labour shortage and training needs, with @CATTI_Training, in the #CGT industry to offer value. @CCRM_ca @3M. Shoutout @NGen_Canada for funding support
Michael May CCRM retweeted
Incredible opportunity to bring so many thought leaders at today’s @3M Canada’s event supported by @OBIOscience, @CCRM_ca and @LifeSciencesON. #lifesciences – at Toronto, Ontario
Earlier today, #OBIO’s President and CEO, Dr. Maura Campbell, was in a panel discussion on “Challenges and Opportunities facing Biomanufacturing in #Ontario” with Jason Field and @MichaelMay5 at a symposium, hosted by @3M, @LifeSciencesON, @CCRM_ca and OBIO.
Michael May CCRM retweeted
Congratulations Sernova!
We have received approval from the @UChicagoMed IRB, with no objections from the US FDA, to enroll patients in a 2nd cohort of our Ph1/2 study in #Type1Diabetes patients who suffer severe hypoglycemic episodes and #HypoglycemiaUnawareness. Learn more: bit.ly/3ftBDM3 #T1D
Michael May CCRM retweeted
Calling early-stage biomanufacturing companies to join bioprocessing experts for an educational symposium on Nov 9. Hosted by @3M, @LifeSciencesON, @CCRM_ca & #OBIO, this is an opportunity to learn and network with industry experts.
Sign up now!
tinyurl.com/yc86bav2
Michael May CCRM retweeted
Highlights the two crunch points in bioprocess scale-up and manufacturing; capacity and competence. Simply insufficient capacity and a skills shortage. sifted.eu/articles/europe-te…
Michael May CCRM retweeted
.@MichaelMay5, President and CEO of CCRM, and @michaelisraels, CFO of CCRM, spent last week in Australia to strengthen ties, nurture collaborations and meet with our partners @CCRM_au
Fantastic reception to host Dr Michael Way, @CCRM_ca Director, at the Canadian Consulate in Sydney! I finally met @carmine_3Dheart today.
Michael May CCRM retweeted
Great to have you in town Bruce. Thanks for your great presentation.
I'm in 🇨🇦 & looking forward to speaking @CCRM_ca @JLABS Cell & Gene Therapy Symposium tomorrow cellandgenetherapysymposium.…













































